Should I buy Macerich (MAC) stock or is it too late?

Macerich · Real Estate · price $23

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Piper Sandler — 58% of its targets hit on this sector (55 calls tested). It aims for $26 (+15 %), call made on October 13, 2026, maturing on October 13, 2027 (1 d ago).

The 1 reliable analyst $26+15 %

The 12 other firms $26+15 %

How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $26 median. “The 12 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Macerich

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Mizuho	56 %	+6.4 %	9	$24 +7%
Piper Sandler	44 %	+5.0 %	9	$26 +15%
Deutsche Bank	78 %	+2.9 %	9	$27 +20%
Morgan Stanley	67 %	+2.6 %	12	$25 +11%
Goldman Sachs	43 %	-13.2 %	7	$19 -16%

In short — Should you invest in Macerich? Is it too late, still worth it? Analysts are fairly positive (77% buy, median target $26, i.e. +15%), and the most reliable on MAC targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

77% of analysts rate it a buy (Buy consensus, 13 ratings) — a sign of market conviction.
Median price target $26, i.e. +15% from the current price ($23).
The most reliable firm on MAC, Truist Securities (100% hit rate, 2 scored calls), targets $26 (call made on June 24, 2026, maturing on June 24, 2027) (+15%) in its most recent call, and $19 (call made on December 19, 2025, maturing on December 19, 2026) (-16%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 13 ratings, 2 are neutral and 1 is a sell.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.

The analyst consensus on MAC

Median target $26 (+15%) · 13 ratings · Buy consensus

Strong Buy00%

Buy1077%

Hold215%

Sell18%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Macerich now?

We won't decide for you. The facts: 77% of analysts rate it a buy, median target $26 (+15%), and Truist Securities (most reliable on MAC, 100%) targets $26. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Macerich?

Not according to analysts: the median target ($26) is still +15% above the current price ($23) (most reliable on MAC: Truist Securities, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Macerich still worth investing in?

It depends on the gap between the price ($23) and its estimated value: analysts target $26 on median (+15%), with 77% buys (most reliable on MAC: Truist Securities, 100%). Cross-check with their real reliability on MAC and the cautions above. Information, not advice.

What's the main risk in buying MAC?

The consensus is not unanimous: of 13 ratings, 2 are neutral and 1 is a sell.

→ Go deeper: the full Macerich profile (consensus, analyst reliability, price target, performance).